Adherence to antiretroviral therapy: An empirical test of the information-motivation-behavioral skills model

Health Psychology

Volumn 25, Issue 2, 2006, Pages 153-162

  Starace, Fabrizio ^a   Massa, Alessandra ^a   Amico, K Rivet ^b   Fisher, Jeffrey D ^b  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adherence; Antiretroviral therapy; HIV; Information motivation behavioral skills model

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EMPIRICISM; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MOTIVATION; PATIENT COMPLIANCE; PREDICTION; SKILL; STATISTICAL SIGNIFICANCE; STRUCTURAL EQUATION MODELING; THEORETICAL MODEL;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; FEMALE; HEALTH SURVEYS; HUMANS; ITALY; MALE; MIDDLE AGED; MODELS, THEORETICAL; MOTIVATION; PATIENT COMPLIANCE; PATIENT EDUCATION;

EID: 33645777258     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.25.2.153     Document Type: Article

References (60)

1. Altice, F. L., & Friedland, G. H. (1998). The era of adherence to HIV therapy. Annals of Internal Medicine, 129, 503-504.
2. Amico, K. R., Toro-Alfonso, J., & Fisher, J. D. (2005). Evaluation of the information, motivation, behavioral skills model of ART adherence: A replication and extension study. AIDS Care 17, 661-673..
3. Arnsten, J. H., Demas, P. A., Farsadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infections Disease, 33(8), 1417-1423.
4. Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. American Journal of Addictions, 10, 69-78.
5. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E., Ciccarone, D., Chesney, M., & Moss, A. R. (2000, February). Provider estimate and structured patient report of adherence compared with unannounced pill count. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco.
6. Bartlett, J. A. (2002). Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndrome, 29, S2-S10.
7. Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., & Kaiser, L., et al. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 21, 114-119.
8. Bollen, K. A. (1989). Structural equations with latent variables. New York: Wiley.
9. Catz, S. L., Kelley, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124-133.
10. Chesney, M. A., Ickovics, J. R., Chambrers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.
11. Chesney, M. A., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599-1605.
12. Cohen, S., Kamark, T., & Marmelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24, 385-396.
13. Fisher, J. D., Amico, K. R., & Christie, S. (2000). The Adherence to Combination Therapy (ACT) Questionnaire and Interview. Unpublished manuscript. Storrs: University of Connecticut.
14. Fisher, J. D., & Fisher, W. A. (1992). Changing AIDS risk behavior. Psychological Bulletin, 111, 455-474.
15. Fisher, J. D., & Fisher, W. A. (2000). Theoretical approaches to individual-level change. In J. Peterson & R. DiClemente (Eds.), HIV prevention handbook (pp. 3-55). New York: Kluwer Academic.
16. Fisher, J. D., & Fisher, W. A. (2002). The information-motivation- behavioral skills model. In R. DiClemente, R. Crosby, & M. Kegler (Eds.), Emerging promotion research and practice (pp. 40-70). San Francisco: Jossey-Bass.
17. Fisher, J. D., Fisher, W. A., Amico, K. R., & Harman, J. J. (in press). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology
18. Fisher, W. A., & Fisher, J. D. (1993). A general psychological model for changing AIDS risk behavior. In J. Pryor & G. Reeder (Eds.), The social psychology of HIV infection (pp. 127-153). Hillsdale, NJ: Erlbaum.
19. Fisher, W. A., Fisher, J. D., & Harman, J. J. (2003). The information-motivation-behavioral skills model as a general model of health behavior change: Theoretical approaches to individual-level change. In J. Suls & K. Wallston (Eds.), Social psychological foundations of health (pp. 127-153). London: Blackwell.
20. Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
21. Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099-1107.
22. Hecht, F. M., Colfax, G., Swanson, M., & Chesney, M. A. (1998, February). Adherence and effectiveness of protease inhibitors in clinical practice. Abstract of presentation given at the 5th conference on Retroviruses and Opportunistic Infections, Chicago.
23. Hecht, F. M., Grant, R. M., Petropoulos, C. J., Chesney, M. A., Tian, H., Hellmann, N. S., et al. (1998). Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. New England Journal of Medicine, 339(5), 307-11.
24. Hirsch, M. S., Conway, B., D'Aquila, R. T., Johnson, V. A., Brun-Vezinet, F., Clotet, B., et al. (1998). Antiretroviral drug resistance testing in adults with HIV infection. Journal of the American Medical Association, 279, 1984-1991.
25. Ho, D. (1998, June 19). Toward HIV eradication or remission: The tasks ahead. Science, 280, 1866-1867.
26. Hogg, R. S., Yip, B., Chan, K., O'Shaughnessy, M. V., & Montaner, S. G. (2000, February). Nonadherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco.
27. Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDS, 13, 185-197.
28. Holzemer, W. L., Henry, S. B., Portillo, C. J., & Miramontes, H. (2000). The client adherence profiling-intervention tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: A pilot study. Journal of the Association of Nurses in AIDS Care, 11, 36-44.
29. Ickovics, J., & Chesney, M. (1997). Issues regarding antiretroviral treatment for patients with HIV-1 infection. Journal of the American Medical Association, 278, 1233-1234.
30. Kalichman, S. (1999, March). Adherence to combination antiretroviral therapies in HIV infected persons of low literacy. Paper presented at the 20th Annual Meeting of the Society of Behavioral Medicine, San Diego, CA.
31. Kalichman, S. C., Rompa, D., DiFonzo, K., Simpson, D., Austin, J., Luke, W., et al. (2001). HIV treatment adherence in women living with HIV/AIDS: Research based on the information-motivation-behavioral skills model of health behavior. Journal of the Association of Nurses in AIDS Care, 12, 58-67.
32. Karnofsky, D. A., Ableman, W. H., Carver, L. F., & Burchenal, J. H. (1948). The use of nitrogen mustards in palliative treatment of carcinoma cancer. Cancer. 1, 634-656.
33. Kleeberger, C. A., Phair, J. P., Strathdee, S. A., Detels, R., Kingsly, L., & Jacobson, L. P. (2001). Effect of computer-assisted self-interviews on reporting of sexual HIV risk behaviours in a general populations sample: A methodological experiment. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 26, 82-92.
34. Kline, R. B. (1998). Principles and practice of structural equation modeling. New York: Guilford.
35. Knobel, H., Alonso, J., Casado, J. L., Collazos, J., Gonzalez, J., Ruiz, I., et al. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS, 16, 605-613.
36. Low-Beer, S., Yip, B., O'Shaughnessy, M., Hogg, R., & Montaner, J. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23, 360-361.
37. Mirowsky, J., & Ross, C. E. (1992). Age and depression. Journal of Health and Social Behavior, 33, 187-205.
38. Moatti, J., Carrieri, M., Spire, B., Gastaut, J., Cassuto, J., & Moreau, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. AIDS, 14, 151-155.
39. Moatti, J. P., & Spire, B. (2000). Living with HIV/AIDS and adherence to antiretroviral treatments. In J.-P. Moatti, Y. Souteyrand, A. Prieur, T. Sandfort, & P. Aggleton (Eds.), AIDS in Europe: New challenges for the social sciences (pp. 57-73). New York: Routledge.
40. Molassiotis, A., Nahas-Lopez, V., Chung, W. Y. R., Lam, S. W. C., Li, C. K. P., & Lau, T. F. J. (2002). Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD & AIDS, 13, 301-310.
41. Murphy, D. A., Wilson, C. M., Durako, S. J., Muenz, L. R., Belzer, M., Friedman, L. et al. (2001). Antiretrovial medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care, 13, 27-40.
42. Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D., et al. (2000). Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 24, 123-128.
43. Muthèn, L. K., & Muthèn, B. O. (2001). MPLUS: Statistical analysis with latent variables user's guide (2nd ed.). Los Angeles: Author.
44. Muthèn, L. K., & Muthèn, B. O. (2002, September). Modeling with categorical latent variables using MPLUS. Course offered at MPLUS Short Courses in Washington, DC.
45. Nieuwkerk, P. T., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Archives of Internal Medicine, 161, 1962-1968.
46. Paterson, D., Swindells, S., Mohr, J., Brester, M., Vergis, E., Squier, C., et al. (1999, February). How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS Caps. Paper presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago.
47. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
48. Pradier, C., Carrieri, P., Bentz, L., Spire, B., Dellamonica, P., & Moreau, J. P. (2001). Impact of short-term adherence on virological and immunological success of HAART: A case study among French HIV-infected IDUs. International Journal of STD & AIDS, 12, 324-328.
49. Rabkin, J., Ferrando, S., van Gorp, W., Rieppi, R., McElhiney, M., & Sewell, M. (2000). Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 451-457.
50. Roca, B., Gomez, C. J., & Arnedo, A. (2000). Adherence, side effects, and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients. Journal of Infection, 41, 50-54.
51. Samet, J. H., Sullivan, L. M., Traphagen, E. T., & Ickovics, J. R. (2001). Measuring adherence among HIV-infected persons: Is MEMS consummate technology? AIDS & Behavior, 5, 21-30.
52. Singh, N., Squier, C., Sivek, C., & Wagener, M. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
53. Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., Moatti, J-P., et al. (2002). Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to dynamic approach. Social Science and Medicine, 54, 1481-1496.
54. Starace, F., Ammassari, A., Trotta, M. P., Murri, R., De Longis, P., Izzo, C., et al. (2002). Depression as risk factor for adherence to HAART. Journal of Acquired Immune Deficiency Syndromes, 31, S136-S139.
55. Starace, F., De Gaetano, A., Chirianni, A., Abrescia, N., Angarano, G., Bonadies, G., et al. (2000, July). Nonadherence in HIV-seropositive persons: Psychosocial factors and implications for treatment. Paper presented at the 13th International AIDS Conference, Durban, South Africa.
56. Tesoriero, J., French, T., Weiss, L., Waters, M., Finkelstein, R., & Agins, B. (2003). Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. Journal of Acquired Immune Deficiency Syndromes, 33, 484-493.
57. Tuldra, A., Fumaz, C. R., Ferrer, M. J., Bayes, R., Arno, A., Balague, M., et al. (2000). Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 25, 221-228.
58. Walsh, J. C., Horne, R., Dalton, M., Burgess, A. P., & Gazzard, B. G. (2001). Reasons for nonadherence to antiretroviral therapy: Patients' perspectives provide evidence of multiple causes. AIDS Care, 13(6), 709-720.
59. Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1-month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological outcome. AIDS 16, 269-277.
60. Zaccarelli, M., Barracchini, A., De Longis, P., Perno, C. F., Soldani, F., Liuzzi, G., et al. (2002). Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine. AIDS Patient Care and STDs, 16, 67-73.